Loading...
PACIFIC-6: a phase II study of durvalumab following sequential chemoradiotherapy in patients with stage III, unresectable NSCLC
Garassino, M Mazieres, J Reck, M Emeribe, U Franks, A Trunova, N
Garassino, M
Mazieres, J
Reck, M
Emeribe, U
Franks, A
Trunova, N
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Garassino M, Faivre-Finn C, Mazieres J, Reck M, Emeribe U, Franks A, et al. P1.01-108 PACIFIC-6: A Phase II Study of Durvalumab Following Sequential Chemoradiotherapy in Patients with Stage III, Unresectable NSCLC. Journal of Thoracic Oncology. 2019;14(10):S403-S4.